Skip to Content
NCI Formulary
Contact NExT
Show menu
Search this site
Last Updated: 05/19/25

Available Agents

Click on column header to sort by Agent Name, Company or Agent Class

Agent Name NSC Number Company Agent Class Agent Target/Molecular Target(s)
Alectinib 794611 Genentech ALK inhibitor, tyrosine kinase inhibitor ALK, RET
Atezolizumab 783608 Genentech PD-L1 blocking monoclonal antibody PD-L1
Avelumab 799232 EMD Serono, Inc. PD-L1 Inhibitor PD-L1
Bevacizumab 704865 Genentech Anti-angiogenesis inhibitor, monoclonal antibody VEGF
Blinatumomab 765986 Amgen Inc Bispecific T-cell engager (BiTE) monoclonal antibody CD3, CD19
Capivasertib 782347 AstraZeneca serine/threonine kinase (AKT) inhibitor AKT 1, AKT 2, AKT 3
Ceralasertib 802785 AstraZeneca ATR kinase inhibitor ATR
Cobimetinib 781257 Genentech MEK1/2 inhibitor MEK1/2
Durvalumab 778709 AstraZeneca PD-L1 blocking monoclonal antibody PD-L1, CD80
Ensartinib 784729 Xcovery Holding Company LLC ALK inhibitor ALK, TrkA, TrkC, ROS, EphA2, c-MET
Giredestrant 840836 Genentech Selective estrogen receptor degrader (SERD) ER-targeting therapy
Glofitamab 845088 Genentech Bispecific monoclonal antibody CD20 expressed on the surface of B cells and CD3 receptor expressed on the surface of T cells.
Inavolisib 843575 Genentech Class I PI3Kα Class I PI3Kα isoform (p110α)
Ipilimumab 732442 Bristol-Myers Squibb anti-CTLA-4 monoclonal anibody CTLA-4
Larotrectinib 788607 Bayer Tyrosine kinase inhibitor NTRK-1, NTRK-2, NTRK-3 gene fusions; TrkA/B/C fusion proteins
Mirdametinib SpringWorks Therapeutics, Inc. MEK1/2 inhibitor MEK1, MEK2
Mogamulizumab 791064 Kyowa Hakko Kirin Co., Ltd. anti-CCR4 monoclonal antibody CC chemokine receptor 4 (CCR4)-expressing cells
Nirogacestat 811402 SpringWorks Therapeutics, Inc. Gamma Secretase Inhibitor Gamma Secretase
Nivolumab 748726 Bristol-Myers Squibb PD-1 blocking monoclonal antibody PD-1
Obinutuzumab 793436 Genentech anti-CD20 monoclonal antibody CD20
Olaparib 747856 AstraZeneca PARP inhibitor PARP-1, PARP-2, PARP-3
Pertuzumab 740102 Genentech anti-HER2 monoclonal antibody HER2/neu
Pertuzumab/trastuzumab/
hyaluronidase-zzxf
827796 Genentech Fully human immunoglobulin monoclonal antibodies Human epidermal growth factor receptor 2 (HER2, also known as c-erbB-2)
Regorafenib 821745 Bayer L01XE21 VEGFR1, VEGFR2, VEGFR3, TIE2, PDGFRB, FGFR1, KIT, RET, RAF1, BRAF
Savolitinib 785348 AstraZeneca MET kinase inhibitor MET
SX-682   Syntrix Biosystems, Inc. CXCR1 and CXCR2 inhibitor CXCR1 and CXCR2 expressing cells
Talimogene laherparepvec 785349 Amgen Inc Genetically modified oncolytic virus  
Tiragolumab 827799 Genentech Fully human immunoglobulin monoclonal antibody T-Cells and natural killer (NK) cell subsets
Trastuzumab 688097 Genentech anti-HER2 monoclonal antibody HER2/neu
Trastuzumab and hyaluronidase-oysk 827797 Genentech Fully human immunoglobulin monoclonal antibody Human epidermal growth factor receptor 2 (HER2, also known as c-erbB-2)
Tremelimumab 744483 AstraZeneca anti-CTLA-4 monoclonal anibody CTLA-4